PhRMA

OCTOBER 6, 2022

The 340B Drug Pricing Program was designed to help vulnerable patients improve access to their medicines through manufacturer discounts to specific safety-net, non-profit hospitals and federally funded clinics. The biopharmaceutical industry has long supported this program, but unfortunately, 340B has strayed far from its purpose, with more and more for-profit health care entities using these discounts for themselves.

Hospitals 254

Hospitals 254

Drug Topics

OCTOBER 6, 2022

Understanding the main causes and staying current on recommendations and treatments will help reduce patient rates of the condition.

187

187

pharmaphorum

OCTOBER 6, 2022

An artificial intelligence-powered digital health worker has been unveiled by the World Health Organisation (WHO) as its latest tool for disseminating reliable health information to the public. Originally developed by New Zealand tech company Soul Machines with support of the Qatar Ministry of Health, the first version of the virtual health worker was used to combat misinformation about the pandemic.

Vaccines 139

Vaccines 139

Pharmacy Times

OCTOBER 6, 2022

Antioxidants are capable of converting highly destructive free radicals and nonradical molecules, thereby reducing cerebral stress.

153

153

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

OCTOBER 6, 2022

The American Revolution had July 4. The allies had D-Day. And now U.S. patients, held down for decades by information hoarders, can rally around a new turning point, October 6, 2022 — the day they got their health data back. Under federal rules taking effect Thursday, health care organizations must give patients unfettered access to their full health records in digital format.

127

127

Pharmacy Times

OCTOBER 6, 2022

Two Houston Methodist cancer researchers were granted a quarter-million dollars each to study some of the most lethal forms cancer, including triple-negative breast cancer and multiple myeloma.

123

123

Pharmacy Times

OCTOBER 6, 2022

New research suggests that psychedelics, and specifically ketamine, can increase neuroplasticity to help a patient with an eating disorder get “unstuck,” and help treat the disorder better than psychotherapy alone.

123

123

Drug Topics

OCTOBER 6, 2022

About 40% of people monkeypox also had HIV, according to a CDC study that included almost 2000 monkeypox cases in the United States that occurred during the first 2 months of the outbreak.

98

98

Pharmacy Times

OCTOBER 6, 2022

Having a platform like Neil in a university to combat equity, diversity, and other measures in the public health space is a unique benefit as a pharmacist.

132

132

Pharmaceutical Technology

OCTOBER 6, 2022

Pfizer has acquired all the outstanding shares of the common stock of biopharmaceutical firm Global Blood Therapeutics (GBT) in a deal worth nearly $5.4bn. The total enterprise value comprised debt and the net of cash acquired. With the latest acquisition, GBT became a wholly-owned Pfizer subsidiary. GBT discovers and develops life-changing therapies for ailments with an initial focus on sickle cell disease (SCD).

FDA 115

FDA 115

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

OCTOBER 6, 2022

Researchers identified a new immunotherapeutic target that may be effectively treated with CAR T-cell therapy in patients with pretreated multiple myeloma.

122

122

Drug Store News

OCTOBER 6, 2022

Now in its 24th year, the Industry Issues Summit is an opportunity to join retail executives at the premier conference for pharmacy, OTC, health, beauty and personal care.

105

105

Pharmacy Times

OCTOBER 6, 2022

Study finds cardioprotective medications were used in approximately 11% more men than women with type 1 diabetes.

123

123

STAT

OCTOBER 6, 2022

The United States is going to direct travelers arriving from Uganda, where a fast-growing Ebola outbreak arose in recent weeks, to five airports where they can be screened for possible infection. Starting Friday, U.S.-bound passengers who have been in Uganda within the past three weeks will be routed to JFK, Newark, Atlanta, O’Hare, or Dulles outside Washington, D.C., according to a statement from the U.S. embassy in Uganda.

99

99

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

OCTOBER 6, 2022

Higher C-reactive protein levels have been linked to cognition problems among older breast cancer survivors.

123

123

STAT

OCTOBER 6, 2022

Buried deep within the Inflation Reduction Act’s drug-price negotiation provisions is language that could open the way to a new era of biomedical breakthroughs and smarter health spending. This language does something Medicare hasn’t tried before: It ties payment for treatments to how well they work. Doing so used to be illegal. But it will now be required for some drugs.

98

98

pharmaphorum

OCTOBER 6, 2022

Biological systems are hugely complex, with a staggering number of pathways interacting every millisecond. The downstream effects of just one biological change are enormous. So, when a new disease emerges, researchers have a near-impossible task working upstream from symptoms to identify the underlying cause and biological mechanisms causing disease.

Dosage 98

Dosage Compounding Hospitals 98

STAT

OCTOBER 6, 2022

WASHINGTON – Here in the U.S., it’s “in” to study the social determinants of health. There are programs at Columbia and Emory dedicated to the field. Papers on the topic garner thousands of citations.The federal health department has even crafted an entire plan for addressing this topic, which is broadly defined as the ways a person’s environment impacts their health.

FDA 95

FDA 95

Drug Store News

OCTOBER 6, 2022

The InfinityRx platform delivers a flexible, mobile and innovative rules engine that electronically drives a targeted price discount or co-pay assistance to high-cost medications at the POS retail level and all sites of care for treatment.

94

94

STAT

OCTOBER 6, 2022

The three companies that dominate the global market for insulin have launched various programs to expand the reach of their medicines in dozens of low and middle-income countries — but their efforts remain patchy and equitable access consequently remains out of reach, according to a new analysis. Too often, the manufacturers — Eli Lilly, Sanofi, and Novo Nordisk — do not understand the extent to which the public and private sectors in many poorer countries can afford insulin

95

95

Pharmacy Times

OCTOBER 6, 2022

High intake of refined grains linked to an increased risk of premature coronary artery disease.

123

123

STAT

OCTOBER 6, 2022

WASHINGTON — A new survey from the CDC and the FDA suggests that youth vaping rates appear to be dropping, compared to pre-pandemic levels. Just over 9% of middle and high schoolers surveyed earlier this year reported currently using e-cigarettes, according to data published Thursday afternoon. Scientists caution against comparing the last few years too directly, given the disruptive effects of the coronavirus pandemic, but in 2019, 20% of middle and high school students reported current

FDA 93

FDA 93

pharmaphorum

OCTOBER 6, 2022

In this instalment of Health Innovators, Paul Tunnah, Healthware’s chief content officer, sits down with Dr Anthony Yanni, senior vice president and global head of patient centricity at Astellas Pharma. “Patient centricity” is a central value as pharma companies look to innovate their products and processes, but is it also in danger of losing its meaning and becoming just another pharma business buzzword?

91

91

STAT

OCTOBER 6, 2022

WASHINGTON — President Joe Biden is pardoning thousands of Americans convicted of “simple possession” of marijuana under federal law, as his administration takes a dramatic step toward decriminalizing the drug and addressing charging practices that disproportionately impact people of color. Biden’s move also covers thousands convicted of the crime in the District of Columbia.

88

88

pharmaphorum

OCTOBER 6, 2022

Servier is already in the process of transforming itself into a much bigger player in cancer, and has just tripled its sales objectives for the category. Fresh with a new brand identity, the France-headquartered pharma group has pledged to grow its oncology sales from its current objective of €1 billion in 2025 to €3 billion in 2030, continuing a diversification of its business from its traditional focus on cardiovascular diseases.

Generic Medicine 89

Generic Medicine Chemotherapy 89

European Pharmaceutical Review

OCTOBER 6, 2022

Microbial identification is a globally expanding market, predicted by new research to hold a value of $3.7 billion by the end of 2022 and $10.7 billion in 2032, propelled by a compound annual growth rate (CAGR) of 11.3 percent, led primarily by the rapid advancement of technology, In 2021, the market share for bacterial identification systems was 28.4 percent.

Compounding 88

Compounding 88

Drug Store News

OCTOBER 6, 2022

The Regenerist Hyaluronic + Peptide 24 collection is formulated to hydrate the skin’s surface and leave a dewy, radiant complexion, the brand said.

98

98

STAT

OCTOBER 6, 2022

In the run-up to an extremely unusual hearing later this month, newly released documents underscore highly contrasting views taken by the U.S. Food and Drug Administration and a manufacturer toward a controversial drug for reducing premature births, which the agency wants withdrawn from the market. For the first time, the FDA has explained in copious detail why agency officials believe the medication, which is called Makena, should be removed.

Documentation 85

Documentation FDA 85

Drug Store News

OCTOBER 6, 2022

The Regenerist Hyaluronic + Peptide 24 collection is formulated to hydrate the skin’s surface and leave a dewy, radiant complexion, the brand said.

97

97

STAT

OCTOBER 6, 2022

Telehealth company Ro has reached an agreement with the National Institute on Aging to create a registry of patients that could participate in Alzheimer’s disease research, a new approach to tackle the stubborn issue of recruitment for clinical trials. Ro, which is best known for prescribing hair loss and erectile dysfunction medication online, will use its platform to recruit and screen patients who may be at risk of Alzheimer’s or dementia.

80

80

Drug Store News

OCTOBER 6, 2022

From the 90 new products that hit store shelves in September, HRG’s new product team found five standouts.

110

110

Outsourcing Pharma

OCTOBER 6, 2022

The Danish company becomes the latest large pharma company to invest in NLRP3 assets, with these types of treatments holding the potential to treat a variety of diseases linked to inflammation.

78

78

European Pharmaceutical Review

OCTOBER 6, 2022

The US Food and Drug Administration (FDA) has approved Roche’s PATHWAY anti-HER2/neu (4B5) Rabbit Monoclonal Primary Antibody (PATHWAY anti-HER2 (4B5) test), which identifies low HER2 expression in metastatic breast cancer. The approval redefines the pool of patients to be optioned for Enhertu (fam-trastuzumab deruxtecan-nxki), a modified HER2-directed antibody drug conjugate (ADC).

Chemotherapy 77

Chemotherapy FDA 77

Drug Store News

OCTOBER 6, 2022

Amar Desai will oversee the implementation of key areas of CVS Health's health services and care delivery strategy.

97

97